Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms

Spine

Volumn 28, Issue 4, 2003, Pages 341-346

  Ahn, Sang Ho ^a,d   Park, Hea Woon ^a   Lee, Bum Suk ^b   Moon, Hae Won ^c   Jang, Sung Ho ^a   Sakong, Joon ^a   Bae, Jang Ho ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b National Rehabilitation Hospital   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d NONE   (South Korea)

Author keywords

Gabapentin; Neuropathic pain; Spinal cord injury

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; GABAPENTIN; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CAUDA EQUINA SYNDROME; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP; SOMNOLENCE; SPINAL CORD INJURY; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

ACETIC ACIDS; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; POLYRADICULOPATHY; SLEEP; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 0037442339     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200302150-00005     Document Type: Article

References (45)

1. Attal N, Gaude V, Brasseur L, et al. Intravenous lidocaine in central pain: A double-blind, placebo-controlled, psychophysical study. Neurology 2000;54:564-74.
2. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998;280:1831-6.
3. Balazy TE. Clinical management of chronic pain in spinal cord injury. Clin J Pain 1992;8:102-10.
4. Bowsher D. Central pain following spinal and supraspinal lesions. Spinal Cord 1999;37:235-8.
5. Chapman V, Suzuki R, Chamarette HL, et al. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998;75:261-72.
6. Chiou-Tan FY, Tuel SM, Johnson JC, et al. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehabil 1996;75:84-7.
7. Cioni B, Meglio M, Pentimalli L, et al. Spinal cord stimulation in the treatment of paraplegic pain. J Neurosurg 1995;82:35-9.
8. Demirel G, Yllmaz H, Gencosmanoglu B, et al. Pain following spinal cord injury. Spinal Cord 1998;36:25-8.
9. Denkers MR, Biagi HL, O'Brien MA, et al. Dorsal root entry zone lesioning used to treat central neuropathic pain in patients with traumatic spinal cord injury. Spine 2002;27:E177-84.
10. Eaton MJ, Martinez MA, Karmally S. A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury. Brain Res 1999; 24:334-9.
11. Eide PK. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury. Spinal Cord 1998;36:601-12.
12. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 1995;37:1080-7.
13. Fenollosa P, Pallares J, Cervera J, et al. Chronic pain in the spinal cord injured: Statistical approach and pharmacological treatment. Paraplegia 1993;31:722-9.
14. Finnerup NB, Johannesen IL, Sindrup SH, et al. Pain and dysesthesia in patients with spinal cord injury: A postal study. Spinal Cord 2001;39:256-62.
15. Gillin S, Sorkin LS. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug. Anesth Analg 1998;86:111-6.
16. Hao JX, Xu XJ, Urban L, et al. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neurosci Lett 2000;280:211-4.
17. Heilporn A. Two therapeutic experiments on stubborn pain in spinal cord lesions: Coupling melitracen-flupenthixol and the transcutaneous nerve stimulation. Paraplegia 1978;15:368-72.
18. Hwang JH, Yaksh TL. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 1997;22:249-56.
19. Kapadia NP, Harden N. Gabapentin for chronic pain in spinal cord injury: A case report. Arch Phys Med Rehabil 2000;81:1439-41.
20. McCaffery M. Gabapentin for lancinating neuropathic pain. Am J Nurs 1998;98:12.
21. McLean MJ, Morrell MJ, Willmore LJ, et al. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia 1999; 40:965-72.
22. Mellick GA, Mellick LB. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil 1997;78:98-105.
23. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-7.
24. Murphy D, Reid DB. Pain treatment satisfaction in spinal cord injury. Spinal Cord 2001;39:44-6.
25. Loeser JD, Ward AA Jt, White LE Jr. Chronic deafferentation of human spinal cord neurons. J Neurosurg 1968;29:48-50.
26. Ness TJ, San Pedto EC, Richards JS, et al. A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin. Pain 1998;78:139-43.
27. New PW, Lim TC, Hill ST, et al. A survey of pain during rehabilitation after acute spinal cord injury. Spinal Cord 1997;35:658-63.
28. Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther 1999;288:1026-30.
29. Putzke JD, Richards JS, Kezar L, et al. Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury. Clin J Pain 2002;18:116-21.
30. Ramsay RE. Clinical efficacy and safety of gabapentin. Neurology 1994;44:S23-30.
31. Ravenscroft A, Ahmed YS, Burnside IG. Chronic pain after SCI: A patient survey. Spinal Cord 2000;38:611-4
32. Rosenberg JM, Harrell C, Ristic H, et al. The effect of gabapentin on neuropathic pain. Clin J Pain 1997;13:251-5.
33. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996;12:56-8.
34. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-42.
35. Samkoff L, Daras M, Tuchman A, et al. Amelioration of refractory dysthetic limb pain in multiple sclerosis by gabapentin. Neurology 1997;49:304-5.
36. Sandford PR, Lindblom LB, Haddox JD. Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury. Arch Phys Med Rehabil 1992;73:300-1.
37. Siddall PJ, Loeser JD. Pain following spinal cord injury. Spinal Cord 2001;39:63-73.
38. Siddall PJ, Molloy AR, Walker S, et al. Efficacy of intrathecal morphine and clonidine in the treatment of neuropathic pain following spinal cord injury. Anesth Analg 2000;91:1493-8,
39. Siddall PJ, Taylor DA, Cousins MJ. Classification of pain following spinal cord injury. Spinal Cord 1997;35:69-75.
40. Sindou M, Mertens P, Wael M. Microsurgical DREZotomy for pain due to spinal cord and/or cauda equina injuries: Long-term results in a series of 44 patients. Pain 2001;92:159-71,
41. Sist TC, Filadota VA II, Miner M, et al. Experience with gabapentin for neuropathic pain in the head and neck: Report of ten cases. Reg Anesth 1997;22:473-8.
42. Stubley LA, Martinez MA, Karmally S, et al. Only early intervention with gamma-aminobutyric acid cell therapy is able to reverse neuropathic pain after partial nerve injury. J Neurotrauma 2001;18:471-7.
43. Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypothesis of gabapentin pharmacology. Epilepsy Res 1998;29:233-49.
44. Ttemont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy. Drugs 60:1029-52.
45. Yoon MH, Yaksh TL. The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in rat. Anesth Analg 1999;89: 434-9.